An RNA-based therapeutic triggering poison exon inclusion in DHX9, a gene involved in Ewing sarcoma, has been exploited to enhance the efficacy of chemotherapy in cancer patients [41]. This evidence concerns the gene DHX9 and Ewing sarcoma.